Skip to main content
CVE-2026-0294VulnerabilityPublished Updated

Privilege Escalation (PE) Vulnerability

Source GCVE Database

0
Compare
Authoritative record:CVE-2026-0294· Medium 6.0

Not known to be exploited · CVSS 6.0 Medium : upgrade to 26.3 when convenient.

Data as of 12 Nov 2026, 23:24 UTC

CVSS 4.0 base score
6.0Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.1% chance of exploitation in 30 days – higher than 6% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
Patch
Available – fixed in 26.3
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:U/AU:N/R:A/V:C/RE:M/U:Amber

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 13 Aug 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 13 Nov 2026.

What to do

Upgrade Prisma Access Agent to 26.3.

Affected software

ProductAffectedFixed in
Palo Alto NetworksPrisma Access AgentAffected
  • <26.3
Fixed in
  • 26.3

AI-suggested

If you cannot patch yet, restrict local access to trusted users only and monitor for suspicious activity related to the Prisma Access Agent on Windows and macOS devices.

Description

CVE-2026-0294 is a privilege escalation vulnerability in the Palo Alto Networks Prisma Access Agent application affecting Windows and macOS devices. It allows a local user to execute code with elevated privileges. Other platforms such as Linux, iOS, Android, and ChromeOS are not affected. The vulnerability has a moderate severity rating and no known exploits in the wild have been reported.

References

Community reviews

Loading reviews…